81 related articles for article (PubMed ID: 8853551)
61. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.
Chen L; Pulsipher M; Chen D; Sieff C; Elias A; Fine HA; Kufe DW
J Clin Invest; 1996 Dec; 98(11):2539-48. PubMed ID: 8958216
[TBL] [Abstract][Full Text] [Related]
62. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging.
Seth P; Brinkmann U; Schwartz GN; Katayose D; Gress R; Pastan Ira ; Cowan K
Cancer Res; 1996 Mar; 56(6):1346-51. PubMed ID: 8640824
[TBL] [Abstract][Full Text] [Related]
63. Adenovirus p53 purging for human breast cancer stem cell products.
Hirai M; Kelsey LS; Maneval DC; Vaillancourt M; Talmadge JE
Acta Haematol; 1999; 101(2):97-105. PubMed ID: 10202240
[TBL] [Abstract][Full Text] [Related]
64. Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
Sharp JG; Bishop MR; Copple B; Greiner TC; Iversen PL; Jackson JD; Joshi SS; Benner EJ; Mann SL; Rao AK; Vose JM
Leuk Lymphoma; 2001 Jul; 42(3):417-27. PubMed ID: 11699407
[TBL] [Abstract][Full Text] [Related]
65. Knockdown of
Hilgendorf S; Vellenga E
Haematologica; 2018 Feb; 103(2):e59-e62. PubMed ID: 29101206
[No Abstract] [Full Text] [Related]
66. HeLa Cells: Contaminating Cultures around the World.
Culliton BJ
Science; 1974 Jun; 184(4141):1058-9. PubMed ID: 17736186
[No Abstract] [Full Text] [Related]
67. The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications.
Tsang JJ; Atkins HL
Oncolytic Virother; 2015; 4():13-23. PubMed ID: 27512666
[TBL] [Abstract][Full Text] [Related]
68. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.
Shayakhmetov DM; Papayannopoulou T; Stamatoyannopoulos G; Lieber A
J Virol; 2000 Mar; 74(6):2567-83. PubMed ID: 10684271
[TBL] [Abstract][Full Text] [Related]
69. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus.
Wroblewski JM; Lay LT; Van Zant G; Phillips G; Seth P; Curiel D; Meeker TC
Cancer Gene Ther; 1996; 3(4):257-64. PubMed ID: 8853551
[TBL] [Abstract][Full Text] [Related]
70. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
71. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
[TBL] [Abstract][Full Text] [Related]
72. Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies, including anaplastic large cell lymphoma and Hodgkin's disease.
Meeker TC; Lay LT; Wroblewski JM; Turturro F; Li Z; Seth P
Clin Cancer Res; 1997 Mar; 3(3):357-64. PubMed ID: 9815692
[TBL] [Abstract][Full Text] [Related]
73. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
74. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]